UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Spatial and temporal diversity in genomic instability processes defines lung cancer evolution

Science (American Association for the Advancement of Science), 2014-10, Vol.346 (6206), p.251-256

2014

Volltextzugriff (PDF)

Carboplatin- or Cisplatin-Based Chemotherapy in First-Line Treatment of Small-Cell Lung Cancer: The COCIS Meta-Analysis of Individual Patient Data

Journal of clinical oncology, 2012-05, Vol.30 (14), p.1692-1698

2012

Volltextzugriff (PDF)

Temozolomide Versus Procarbazine, Lomustine, and Vincristine in Recurrent High-Grade Glioma

Journal of clinical oncology, 2010-10, Vol.28 (30), p.4601-4608

2010

Volltextzugriff (PDF)

Cost-effectiveness of first-line erlotinib in patients with advanced non-small-cell lung cancer unsuitable for chemotherapy

BMJ open, 2015-07, Vol.5 (7), p.e006733-e006733

2015

Volltextzugriff (PDF)

Pembrolizumab in patients with non-small-cell lung cancer of performance status 2 (PePS2): a single arm, phase 2 trial

The lancet respiratory medicine, 2020-09, Vol.8 (9), p.895-904

2020

Volltextzugriff (PDF)

Impact of EGFR Inhibitor in Non―Small Cell Lung Cancer on Progression-Free and Overall Survival: A Meta-Analysis

JNCI : Journal of the National Cancer Institute, 2013-05, Vol.105 (9), p.595-605

2013

Volltextzugriff (PDF)

Randomized Trial of Erlotinib Plus Whole-Brain Radiotherapy for NSCLC Patients With Multiple Brain Metastases

JNCI : Journal of the National Cancer Institute, 2014-07, Vol.106 (7), p.1

2014

Volltextzugriff (PDF)

A declining CD4 count and diagnosis of HIV-associated Hodgkin lymphoma: do prior clinical symptoms and laboratory abnormalities aid diagnosis?

PloS one, 2014-02, Vol.9 (2), p.e87442-e87442

2014

Volltextzugriff (PDF)

Vaccine effectiveness against COVID-19 breakthrough infections in patients with cancer (UKCCEP): a population-based test-negative case-control study

The lancet oncology, 2022-06, Vol.23 (6), p.748-757

2022

Volltextzugriff (PDF)

Optimising fusion detection through sequential DNA and RNA molecular profiling of non-small cell lung cancer

Lung cancer (Amsterdam, Netherlands), 2021-11, Vol.161, p.55-59

2021

Volltextzugriff (PDF)

Anti-angiogenic Therapy Using Thalidomide Combined With Chemotherapy in Small Cell Lung Cancer: A Randomized, Double-Blind, Placebo-Controlled Trial

JNCI : Journal of the National Cancer Institute, 2009-08, Vol.101 (15), p.1049-1057

2009

Volltextzugriff (PDF)

A population-scale temporal case-control evaluation of COVID-19 disease phenotype and related outcome rates in patients with cancer in England (UKCCP)

Scientific reports, 2023-07, Vol.13 (1), p.11327-11327, Article 11327

2023

Volltextzugriff (PDF)

Remission After Radiotherapy for a Patient With Chemotherapy-Refractory HIV-Associated Primary Effusion Lymphoma

Journal of clinical oncology, 2008-11, Vol.26 (32), p.5297-5299

2008

Volltextzugriff (PDF)

Axitinib for the treatment of advanced non-small-cell lung cancer

Expert opinion on investigational drugs, 2013-06, Vol.22 (6), p.765-773

2013

Volltextzugriff (PDF)

Randomized Double-Blind Placebo-Controlled Trial of Thalidomide in Combination With Gemcitabine and Carboplatin in Advanced Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2009-11, Vol.27 (31), p.5248-5254

2009

Volltextzugriff (PDF)

STAT3 cyclic oligonucleotide decoy—a new therapeutic avenue for NSCLC?

Translational lung cancer research, 2018-12, Vol.7 (S4), p.S381-S384

2018

Volltextzugriff (PDF)

Pembrolizumab plus Chemotherapy in Metastatic Non–Small-Cell Lung Cancer

The New England journal of medicine, 2018-05, Vol.378 (22), p.2078-2092

2018

Volltextzugriff (PDF)

A potential new enriching trial design for selecting non‐small‐cell lung cancer patients with no predictive biomarker for trials based on both histology and early tumor response: further analysis of a thalidomide trial

Cancer medicine (Malden, MA), 2013-06, Vol.2 (3), p.360-366

2013

Volltextzugriff (PDF)

Highly active antiretroviral therapy alone may be an effective treatment for HIV-associated multicentric Castleman's disease

Haematologica (Roma), 2010-11, Vol.95 (11), p.1979-1981

2010

Volltextzugriff (PDF)

Randomized Phase II Study of Docetaxel Versus Doxorubicin in First- and Second-Line Chemotherapy for Locally Advanced or Metastatic Soft Tissue Sarcomas in Adults: A Study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group

Journal of clinical oncology, 2000-05, Vol.18 (10), p.2081-2086

2000

Volltextzugriff (PDF)

Tumor lysis syndrome after treatment with docetaxel for non-small-cell lung cancer

Journal of clinical oncology, 2006-05, Vol.24 (15), p.2389-2391

2006

Volltextzugriff (PDF)

Metastatic non-small-cell lung cancer: consensus on pathology and molecular tests, first-line, second-line, and third-line therapy 1st ESMO Consensus Conference in Lung Cancer; Lugano 2010

Annals of oncology, 2011-07, Vol.22 (7), p.1507-1519

2011

Volltextzugriff (PDF)

Highly active antiretroviral therapy alone may be an effective treatment for HIV-associated multi-centric Castleman's disease

Haematologica (Roma), 2010-11, Vol.95 (11), p.1979-1981

2010

Volltextzugriff (PDF)

1 – 25 von 92

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(83)
Mit Volltextzugriff
(69)

Publikationsform

Sprache

Englisch
(92)

Erscheinungsjahr

n.n

Thema

Humans
(53)
Science & Technology
(52)
Life Sciences & Biomedicine
(47)
Oncology
(36)
Male
(34)
Female
(32)
Middle Aged
(28)
Adult
(24)
Lung Neoplasms - Drug Therapy
(23)
Aged
(22)
Biological And Medical Sciences
(20)
Medical Sciences
(20)
Chemotherapy
(18)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(17)
Tumors
(17)
Lung Cancer
(16)
Disease-Free Survival
(15)
Lung Neoplasms - Pathology
(15)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(14)
Treatment Outcome
(14)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Spatial and temporal diversity in genomic instability processes defines lung cancer evolution

Carboplatin- or Cisplatin-Based Chemotherapy in First-Line Treatment of Small-Cell Lung Cancer: The COCIS Meta-Analysis of Individual Patient Data

Temozolomide Versus Procarbazine, Lomustine, and Vincristine in Recurrent High-Grade Glioma

Cost-effectiveness of first-line erlotinib in patients with advanced non-small-cell lung cancer unsuitable for chemotherapy

Pembrolizumab in patients with non-small-cell lung cancer of performance status 2 (PePS2): a single arm, phase 2 trial

First-line atezolizumab monotherapy versus single-agent chemotherapy in patients with non-small-cell lung cancer ineligible for treatment with a platinum-containing regimen (IPSOS): a phase 3, global, multicentre, open-label, randomised controlled study

Impact of EGFR Inhibitor in Non―Small Cell Lung Cancer on Progression-Free and Overall Survival: A Meta-Analysis

Randomized Trial of Erlotinib Plus Whole-Brain Radiotherapy for NSCLC Patients With Multiple Brain Metastases

A declining CD4 count and diagnosis of HIV-associated Hodgkin lymphoma: do prior clinical symptoms and laboratory abnormalities aid diagnosis?

Vaccine effectiveness against COVID-19 breakthrough infections in patients with cancer (UKCCEP): a population-based test-negative case-control study

Optimising fusion detection through sequential DNA and RNA molecular profiling of non-small cell lung cancer

First-line erlotinib in patients with advanced non-small-cell lung cancer unsuitable for chemotherapy (TOPICAL): a double-blind, placebo-controlled, phase 3 trial

Anti-angiogenic Therapy Using Thalidomide Combined With Chemotherapy in Small Cell Lung Cancer: A Randomized, Double-Blind, Placebo-Controlled Trial

A population-scale temporal case-control evaluation of COVID-19 disease phenotype and related outcome rates in patients with cancer in England (UKCCP)

Remission After Radiotherapy for a Patient With Chemotherapy-Refractory HIV-Associated Primary Effusion Lymphoma

Axitinib for the treatment of advanced non-small-cell lung cancer

Randomized Double-Blind Placebo-Controlled Trial of Thalidomide in Combination With Gemcitabine and Carboplatin in Advanced Non–Small-Cell Lung Cancer

STAT3 cyclic oligonucleotide decoy—a new therapeutic avenue for NSCLC?

Pembrolizumab plus Chemotherapy in Metastatic Non–Small-Cell Lung Cancer

A potential new enriching trial design for selecting non‐small‐cell lung cancer patients with no predictive biomarker for trials based on both histology and early tumor response: further analysis of a thalidomide trial

Highly active antiretroviral therapy alone may be an effective treatment for HIV-associated multicentric Castleman's disease

Randomized Phase II Study of Docetaxel Versus Doxorubicin in First- and Second-Line Chemotherapy for Locally Advanced or Metastatic Soft Tissue Sarcomas in Adults: A Study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group

Tumor lysis syndrome after treatment with docetaxel for non-small-cell lung cancer

Metastatic non-small-cell lung cancer: consensus on pathology and molecular tests, first-line, second-line, and third-line therapy 1st ESMO Consensus Conference in Lung Cancer; Lugano 2010

Highly active antiretroviral therapy alone may be an effective treatment for HIV-associated multi-centric Castleman's disease

Suchergebnisse filtern